Setting the Stage for COPD Treatment Success Through Patient Engagement, Medication Adherence, and Timely Therapy Escalation

Setting the Stage for COPD Treatment Success Through Patient Engagement, Medication Adherence, and Timely Therapy Escalation

Tune in to this multi-accredited video to hear dynamic discussions between two COPD experts as they explore factors to optimize adherence and outcomes for patients with this disease, including: Adherence tools and remote patient monitoring Shared decision-making to select the most appropriate treatment and delivery device for each individual patient Maintenance therapies that can improve adherence Escalation of treatment to improve symptoms and exacerbation risk In addition, patient perspectives gathered from surveys addressing these topics will be interwoven throughout the presentation.

  • Provider:PRIME Education, Inc. (PRIME®)
  • Activity Link: https://primeinc.org/online/setting-stage-copd-treatment-success-leveraging-digital-health-remote
  • Start Date: 2024-11-26 06:00:00
  • End Date: 2024-11-26 06:00:00
  • Credit Details: IPCE Credits: 1.0 hours
    AAPA Category 1 Credit™️: 1.0 hours
    AMA PRA Category 1 Credit™️: 1.0 hours
    Nursing: 1.0 hours
    Pharmacy: 1.0 hours
  • Commercial Support: Source: Viatris - Amount: 45000.0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner/Team Competence, Learner/Team Performance
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.